Trial
NCT00080119
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID); Comprehensive International Program of Research on AIDS; Secure the Future Foundation
Condition
HIV Infection
Intervention
Isoniazid (INH)
Why stopped
Data Safety Monitoring Board (DSMB) recommended stopping study due to futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-05